BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Moffitt Cancer Center Release: Data Presented at American Society of Clinical Oncology Finds REVLIMID as a Monotherapy is Effective and Well-Tolerated for Previously Treated Multiple Myeloma Patients

  June 2, 2008

   · 

  1 min read
• Drug Development

  Clarification on Press Release Issued Earlier Today: Targeted Genetics Corporation Confirms Positive, Interim Phase 1/2 Study Findings; Trial Demonstrates Safety and Preliminary Efficacy and Supports Further Clinical Development of tgAAC94, Data Presented

  June 2, 2008

   · 

  3 min read
• Drug Development

  AMAG Pharmaceuticals, Inc. Announces Presentation of Positive Results from Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapy in Kidney Transplant Recipients at the American Transplant Congress

  June 2, 2008

   · 

  1 min read
• BioMidwest

  APP Pharmaceuticals Launches Enhanced Labeling for Heparin Sodium Injection, USP

  June 2, 2008

   · 

  1 min read
• Biotech Beach

  Metabasis Therapeutics, Inc. to Present at the American Diabetes Association Meeting and at the Canaccord Adams Diabetes & Obesity Conference

  June 2, 2008

   · 

  1 min read
• Drug Development

  Wyeth Pharmaceuticals (Pennsylvania) Release: New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma - Data From Phase 3 Study Presented at American Society of Clinical Oncology

  June 2, 2008

   · 

  9 min read
• Drug Development

  Bionovo, Inc. Release: Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles - Results Presented at American Society of Clinical Oncology 44TH Annual Meeting

  June 2, 2008

   · 

  5 min read
• Pharm Country

  Lannett Company, Inc. to Launch Amantadine Hydrochloride Soft Gel Capsules, 100 mg

  June 2, 2008

   · 

  1 min read
• Drug Development

  Pfizer Inc. Release: Updated CDX-110 Data in Glioblastoma Multiforme Presented at 44th Annual American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  1 min read
• Drug Development

  Rexahn Pharmaceuticals, Inc. Initiates Phase II Trial for ZoraxelTM to Treat Erectile Dysfunction

  June 2, 2008

   · 

  1 min read